|
Market Closed -
Nasdaq
20:00:00 30/10/2026 GMT
|
5-day change | 1st Jan Change | ||
| 322.75 USD | +1.71% |
|
+6.33% | +70.70% |
Stock exchange
Nasdaq
LGND 322.75 $
+1.71%
111M
$
| Markets | Price | Change | Volumes | ||
|---|---|---|---|---|---|
| LGND | 322.75USD | +1.71% | 111M $ | ||
CBOE
| LGND | 322.23USD | +1.36% | 2.05M $ | |
|
Boerse Muenchen
| LGDN | 290.00EUR | +2.11% | 6.38K € | |
|
Deutsche Boerse AG
| LGDN | 280.00EUR | +0.72% | 0 € | |
|
Tradegate
| LGDN | 290.00EUR | +0.69% | 0 € | |
|
Börse Stuttgart
| LGDN | 288.00EUR | +2.13% | 0 € | |
|
Berne S.E.
| LGDN | 263.74CHF | +0.84% | 0 CHF |
Quotes 5-day view: Ligand Pharmaceuticals Incorporated
Delayed Quote Nasdaq
| 26/10/2026 | 27/10/2026 | 28/10/2026 | 29/10/2026 | 30/10/2026 | |
|---|---|---|---|---|---|
| Last | US$308.30 | US$311.73 | US$318.78 | US$317.33 | US$322.75 |
| Volume | 194,782 | 143,353 | 268,467 | 299,391 | 344,311 |
| Change | +1.57% | +1.11% | +2.26% | -0.45% | +1.71% |
| Opening | US$304.39 | US$308.51 | US$311.62 | US$315.15 | US$319.22 |
| High | US$309.43 | US$314.19 | US$319.90 | US$323.82 | US$324.90 |
| Low | US$303.47 | US$307.55 | US$309.69 | US$309.63 | US$314.51 |
Performance
| 1 day | +1.71% | ||
| 1 week | +6.33% | ||
| 1 month | +3.32% | ||
| 3 months | +12.25% | ||
| 6 months | +40.66% | ||
| Current year | +70.70% | ||
| 1 year | +68.71% | ||
| 3 years | +517.23% | ||
| 5 years | +121.15% | ||
| 10 years | +237.15% |
Volumes
marketsDaily volume
344,311
Estimated daily volume
344,311
Avg. Volume 20 sessions
226,257
Daily volume ratio
1.52
Avg. Volume 20 sessions USD
73,024,446.75
Record volume 1
8,575,945
Record volume 2
5,579,534
Record volume 3
4,904,028
Capital turnover ratio
0.01
Float rotation
0.01
Basic data
Market Cap (USD)
6,434,217,804
Net sales (USD)
268,087,000
Number of employees
47
Sales / Employee (USD)
5,703,979
Free-Float
97.68%
Free-Float capitalization (USD)
6,284,945,929
Average Daily Capital Traded
1.13%
Indicators
Moving average 5 days
315.78
Moving average 20 days
304.32
Moving average 50 days
295.68
Moving average 100 days
294.91
Price spread / (MMA5)
-2.16%
Price spread / (MMA20)
-5.71%
Price spread / (MMA50)
-8.39%
Price spread / (MMA100)
-8.62%
RSI 9 days
62.97
RSI 14 days
60.35
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.71% | +6.33% | +68.71% | +517.23% | 6.43B | |
| +3.19% | +11.31% | +64.28% | +155.91% | 1,263B | |
| -0.73% | +3.56% | +44.65% | +84.17% | 658B | |
| +1.41% | +3.24% | +35.25% | +108.88% | 521B | |
| +0.42% | +3.20% | +54.15% | +67.18% | 391B | |
| +2.18% | +2.93% | +73.90% | +45.59% | 369B | |
| +1.12% | +4.52% | +35.30% | +58.08% | 307B | |
| +6.96% | +8.86% | +11.27% | +36.62% | 290B | |
| +1.15% | +6.09% | +56.15% | +82.25% | 252B | |
| +3.06% | +9.38% | +42.48% | +117.32% | 212B | |
| Average | +2.05% | +5.94% | +48.61% | +127.32% | 426.84B | |
| Weighted average by Cap. | +2.01% | +6.60% | +50.38% | +100.59% |
Historical Quotes: Ligand Pharmaceuticals Incorporated
| Date | Opening | High | Low | Close | Volume | Change |
|---|
Latest transactions
2d93.w6nJ1yKw8FRmOdaUUsZ5OcmHMkFAQXdUIO1XYWUX48Y.psWOgmCAgDMKX4LhYq4DcZ7TUXF3IiEndIVnBzJh0an72bqYUN3FZjMNlw
| Date | Price | Volume | Total |
|---|---|---|---|
| 20:00:00 | 322.75 | 43,386 | 166,201 |
| 19:59:59 | 322.83 | 230 | 122,815 |
| 19:59:59 | 322.70 | 200 | 122,585 |
| 19:59:59 | 322.66 | 200 | 122,385 |
| 19:59:59 | 322.66 | 151 | 122,185 |
| 19:59:59 | 322.47 | 105 | 122,034 |
| 19:59:58 | 322.84 | 103 | 121,929 |
| 19:59:53 | 322.89 | 100 | 121,826 |
| 19:59:53 | 322.90 | 100 | 121,726 |
| 19:59:48 | 322.78 | 100 | 121,626 |
Price Extremes
| 1 week | 303.47 |  | 324.9 |
| 1 month | 281.74 | | 324.9 |
| Current year | 175.89 | | 326.63 |
| 1 year | 175.89 | | 326.63 |
| 3 years | 51.21 | | 326.63 |
| 5 years | 49.24 | | 326.63 |
| 10 years | 49.24 | | 326.63 |
Monthly variations
Annual variations
| 2026 | +70.70% | ||
| 2025 | +76.45% | ||
| 2024 | +50.03% | ||
| 2023 | +6.92% | ||
| 2022 | -56.75% | ||
| 2021 | +55.31% | ||
| 2020 | -4.64% | ||
| 2019 | -23.15% | ||
| 2018 | -0.90% | ||
| 2017 | +34.76% | ||
| 2016 | -6.28% | ||
| 2015 | +103.76% | ||
| 2014 | +1.16% | ||
| 2013 | +153.62% | ||
| 2012 | +74.73% | ||
| 2011 | +33.07% | ||
| 2010 | -31.49% | ||
| 2009 | -20.80% | ||
| 2008 | -43.27% | ||
| 2007 | -55.89% | ||
| 2006 | -1.79% | ||
| 2005 | -4.21% | ||
| 2004 | -20.76% | ||
| 2003 | +173.56% | ||
| 2002 | -70.00% | ||
| 2001 | +27.86% | ||
| 2000 | +8.74% | ||
| 1999 | +10.75% | ||
| 1998 | -9.71% | ||
| 1997 | -13.45% | ||
| 1996 | +38.37% | ||
| 1995 | +30.30% | ||
| 1994 | -17.50% |
- Stock Market
- Stocks
- LGND Stock
- Quotes Ligand Pharmaceuticals Incorporated
Select your edition
All financial news and data tailored to specific country editions
